Sun Pharma Advanced Research Company reports consolidated net loss of Rs 20.78 crore in the June 2026 quarter,
Net Loss of Sun Pharma Advanced Research Company reported to Rs 20.78 crore in the quarter ended June 2026 as against net loss of Rs 51.87 crore during the previous quarter ended June 2025. Sales rose 314.11% to Rs 39.92 crore in the quarter ended June 2026 as against Rs 9.64 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales39.929.64 314 OPM %-85.17-540.25 - PBDT-18.47-49.13 62 PBT-20.67-51.81 60 NP-20.78-51.87 60 Powered by Capital Market - Live News
Sun Pharma Advanced Research Company to discuss results,
Sun Pharma Advanced Research Company will hold a meeting of the Board of Directors of the Company on 10 August 2026.
Sun Pharma Advanced Research Company AGM scheduled,
Sun Pharma Advanced Research Company announced that the 21th Annual General Meeting(AGM) of the company will be held on 10 August 2026.
Sun Pharma Advanced Research Company raises Rs 150 cr via warrant issuance,
Sun Pharma Advanced Research Company has allotted 3,85,10,000 warrants to Shanghvi Finance at an issue price of Rs 155.80/- per warrant on preferential basis, out of which the Company has received an amount of Rs 149.99 crore which is equivalent to 25% of the warrant issue price. Each of the Warrant, so allotted, is convertible into or exchangeable for one fully paid-up equity share of face value of Re 1/- of the Company in accordance with the provisions of SEBI ICDR Regulations.
Sun Pharma Advanced Research Company reports consolidated net profit of Rs 1761.34 crore in the March 2026 quarter,
Net profit of Sun Pharma Advanced Research Company reported to Rs 1761.34 crore in the quarter ended March 2026 as against net loss of Rs 59.77 crore during the previous quarter ended March 2025. Sales declined 51.45% to Rs 13.20 crore in the quarter ended March 2026 as against Rs 27.19 crore during the previous quarter ended March 2025.For the full year,net profit reported to Rs 1553.20 crore in the year ended March 2026 as against net loss of Rs 342.51 crore during the previous year ended March 2025. Sales declined 45.45% to Rs 39.15 crore in the year ended March 2026 as against Rs 71.77 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales13.2027.19 -51 39.1571.77 -45 OPM %13433.33-195.59 -4083.68-450.24 - PBDT1763.36-57.72 LP 1575.58-330.39 LP PBT1760.96-60.67 LP 1565.37-342.78 LP NP1761.34-59.77 LP 1553.20-342.51 LP Powered by Capital Market - Live News
Subscribe for our
newsletter
Open Account Now